JP2013543491A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013543491A5 JP2013543491A5 JP2013530571A JP2013530571A JP2013543491A5 JP 2013543491 A5 JP2013543491 A5 JP 2013543491A5 JP 2013530571 A JP2013530571 A JP 2013530571A JP 2013530571 A JP2013530571 A JP 2013530571A JP 2013543491 A5 JP2013543491 A5 JP 2013543491A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- medicament according
- administered
- compound
- value
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201070427 | 2010-10-01 | ||
| DKPA201070427 | 2010-10-01 | ||
| PCT/DK2011/050375 WO2012041334A1 (en) | 2010-10-01 | 2011-09-30 | Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013543491A JP2013543491A (ja) | 2013-12-05 |
| JP2013543491A5 true JP2013543491A5 (https=) | 2014-06-05 |
Family
ID=44872128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013530571A Pending JP2013543491A (ja) | 2010-10-01 | 2011-09-30 | 急性外傷性凝固障害及び蘇生した心停止の予防または処置に使用するための血管内皮の完全性を調節または保存できる化合物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20130261177A1 (https=) |
| EP (1) | EP2622354A1 (https=) |
| JP (1) | JP2013543491A (https=) |
| KR (1) | KR20140025303A (https=) |
| CN (2) | CN106038570A (https=) |
| AU (1) | AU2011307494B2 (https=) |
| BR (1) | BR112013007849A2 (https=) |
| CA (1) | CA2812846A1 (https=) |
| WO (1) | WO2012041334A1 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104721825B (zh) | 2009-06-12 | 2019-04-12 | 曼金德公司 | 具有确定比表面积的二酮哌嗪颗粒 |
| CA2832992A1 (en) * | 2011-04-19 | 2012-10-26 | Rigshospitalet | Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage |
| EP2834642A1 (en) * | 2012-03-30 | 2015-02-11 | Rigshospitalet | Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest |
| CN104837806A (zh) | 2012-12-07 | 2015-08-12 | 开曼化学股份有限公司 | 前列环素类似物的合成方法 |
| US9505737B2 (en) | 2013-01-11 | 2016-11-29 | Corsair Pharma, Inc. | Treprostinil derivative compounds and methods of using same |
| EP3712142B1 (en) * | 2013-01-11 | 2022-07-06 | Corsair Pharma, Inc. | Prodrugs of treprostinil |
| AU2014228415B2 (en) | 2013-03-15 | 2018-08-09 | Mannkind Corporation | Microcrystalline diketopiperazine compositions and methods |
| MX375448B (es) | 2013-07-18 | 2025-03-06 | Mannkind Corp | Composiciones farmacéuticas en polvo seco estables al calor y métodos. |
| CN105722812B (zh) * | 2013-11-13 | 2018-11-16 | 开曼化学股份有限公司 | 前列环素类似物的胺盐 |
| CN107250375A (zh) | 2014-11-06 | 2017-10-13 | 科罗拉多州立大学董事会 | 在血栓溶解剂存在下使用粘弹性分析鉴定新疾病状态 |
| WO2016123163A2 (en) | 2015-01-27 | 2016-08-04 | Kardiatonos, Inc. | Biomarkers of vascular disease |
| CN107430136A (zh) * | 2015-02-03 | 2017-12-01 | 科罗拉多州立大学董事会,公司实体 | 粘弹性分析用于预测大量出血的用途 |
| EP3278112B1 (en) | 2015-03-29 | 2021-09-22 | Endothel Pharma ApS | A composition comprising prostacyclin or analogues thereof for treatment of acute critically ill patients |
| US11187710B2 (en) | 2015-06-08 | 2021-11-30 | The Regents Of The University Of Colorado, A Body Corporate | Time independent viscoelastic analysis parameter for prediction of patient outcome |
| EP3455366A4 (en) | 2016-05-11 | 2020-02-26 | Michael P. Chapman | ANALYSIS OF VISCOELASTICITY IN PATIENTS WITH A DISEASE ASSOCIATED WITH THE CARDIOVASCULAR SYSTEM |
| US10806801B2 (en) * | 2017-06-07 | 2020-10-20 | National Cheng Kung University | Pharmaceutical composition and methods for using the same |
| US12440285B2 (en) * | 2021-01-22 | 2025-10-14 | Cilag Gmbh International | Prediction of hemostasis issues based on biomarker monitoring |
| US12105099B2 (en) * | 2021-04-28 | 2024-10-01 | Diotex Diagnostics, Llc | Methods and devices for quantitatively estimating syndecan-1 |
| CN114113641B (zh) * | 2021-10-28 | 2023-11-03 | 中科精瓒(武汉)医疗技术有限公司 | 一种活化凝血检测试剂及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58164512A (ja) * | 1982-03-25 | 1983-09-29 | Ono Pharmaceut Co Ltd | プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤 |
| WO1993025220A1 (en) * | 1992-06-05 | 1993-12-23 | Reid Thomas J Iii | Test for quantitative thrombin time |
| JPH11322612A (ja) * | 1998-03-13 | 1999-11-24 | Toray Ind Inc | 肝細胞増殖因子誘引剤 |
| CN2757804Y (zh) * | 2004-11-19 | 2006-02-15 | 杨俊玉 | 心脏按压复苏指示装置 |
| EP2063273A1 (en) * | 2007-11-21 | 2009-05-27 | Pentapharm GmbH | Method for assessing the fibrinogen contribution in coagulation |
| US20100144597A1 (en) * | 2008-12-10 | 2010-06-10 | Ward Kevin R | Novel combinatorial approaches to enhancing oxygen transport to tissues |
| MX2011006995A (es) * | 2008-12-30 | 2011-09-27 | Thrombologic Aps | Metodos para identificar pacientes criticamente enfermos en riesgo incrementado de desarrollar nsuficiencia organica y compuestos para el tratamiento de la misma. |
| US20130023473A1 (en) * | 2010-01-20 | 2013-01-24 | Stephane Germain | Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity |
-
2011
- 2011-09-30 KR KR1020137010342A patent/KR20140025303A/ko not_active Withdrawn
- 2011-09-30 US US13/877,285 patent/US20130261177A1/en not_active Abandoned
- 2011-09-30 CA CA2812846A patent/CA2812846A1/en not_active Abandoned
- 2011-09-30 AU AU2011307494A patent/AU2011307494B2/en not_active Ceased
- 2011-09-30 CN CN201610390867.1A patent/CN106038570A/zh active Pending
- 2011-09-30 EP EP11773168.7A patent/EP2622354A1/en not_active Withdrawn
- 2011-09-30 BR BR112013007849A patent/BR112013007849A2/pt not_active IP Right Cessation
- 2011-09-30 CN CN201180057292.7A patent/CN103238070B/zh not_active Expired - Fee Related
- 2011-09-30 WO PCT/DK2011/050375 patent/WO2012041334A1/en not_active Ceased
- 2011-09-30 JP JP2013530571A patent/JP2013543491A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013543491A5 (https=) | ||
| Yin et al. | Efficacy and tolerability of sufentanil, dexmedetomidine, or ketamine added to propofol-based sedation for gastrointestinal endoscopy in elderly patients: a prospective, randomized, controlled trial | |
| JP2013522212A5 (https=) | ||
| FI3645002T3 (fi) | Menetelmiä sydämen vajaatoiminnan hoitamiseksi sydämen sarkomeerin aktivaattoreilla | |
| JP2016512564A5 (https=) | ||
| FI3626270T3 (fi) | Sydän- ja verisuonitautien hoito | |
| Lee et al. | Cardiorespiratory and anesthetic effects produced by the combination of butorphanol, medetomidine and alfaxalone administered intramuscularly in Beagle dogs | |
| RU2015134581A (ru) | Доноры нитроксила с улучшенным терапевтическим индексом | |
| JP2016516016A5 (https=) | ||
| JP2013532658A5 (https=) | ||
| JP2016520089A5 (https=) | ||
| JP2016527202A5 (https=) | ||
| RU2014141893A (ru) | Применение производной пиразола в лечении острых приступов хронической обструктивной болезни легких | |
| JP2012502103A5 (https=) | ||
| JP2018531605A5 (https=) | ||
| RU2015127834A (ru) | Способы лечения диабета путем введения антагониста рецептора глюкагона в сочетании с ингибитором поглощения холестерина | |
| Amin et al. | Comparative study of neuromuscular blocking and hemodynamic effects of rocuronium and cisatracurium under sevoflurane or total intravenous anesthesia | |
| JP2016520114A5 (https=) | ||
| JP2016510040A5 (https=) | ||
| JP2023020885A5 (https=) | ||
| JP2015512923A5 (https=) | ||
| CN103655549B (zh) | Myrtucommuacetalone在治疗或预防急性心衰药物中的应用 | |
| CN103520161B (zh) | 一种解决长效酰胺类局麻药所致心脏停搏的药物组合 | |
| JP2016503406A5 (https=) | ||
| Singh et al. | Attenuation of Cardiovascular response by ß-blocker esmolol during laryngoscopy and intubation |